Frédéric Genin
About Frédéric Genin
Frédéric Genin serves as the President of IBA Proton Therapy North America, a position he has held since 2019. With a long history at IBA, he has occupied various roles in product management, R&D, and marketing, contributing significantly to the field of proton therapy.
Work at IBA
Frédéric Genin has held multiple positions at IBA, contributing significantly to the field of proton therapy. He has served as President of IBA Proton Therapy North America since 2019, overseeing operations in Washington DC and Belgium. Prior to this role, he was the Chief Product & Marketing Officer for Proton Therapy from 2017 to 2019 and the Executive Vice President of Product Management from 2007 to 2010. His career at IBA began in 1992 as an R&D Project Manager, and he has held various leadership roles, including Vice President of R&D Proton Therapy and CEO of Radiation Dynamics Inc., part of the IBA group.
Education and Expertise
Frédéric Genin has a strong educational background with a focus on engineering and business management. He earned a Master of Engineering (MEng) in Electronics from Haute Ecole Leonard de Vinci in Brussels, Belgium. He also completed several executive education programs at INSEAD, including Strategic Alliances/Networking in 2013, Strategic R&D Management in 2007, and the Young Manager Program in 2001. These educational experiences have equipped him with skills in strategic management and partnership development.
Background
Frédéric Genin's career spans over three decades, primarily within the IBA organization. He has progressed through various roles, starting as an R&D Project Manager in the early 1990s and advancing to executive leadership positions. His experience encompasses product management, research and development, and production technology. This extensive background in the proton therapy sector has positioned him as a key figure in advancing treatment technologies.
Achievements
Throughout his career at IBA, Frédéric Genin has been instrumental in the development and management of proton therapy products. His leadership roles have included overseeing product management and marketing strategies that have contributed to the growth of IBA's proton therapy division. His strategic insights and management skills have played a significant role in enhancing the company's position in the healthcare technology market.